3 papers in the library · 30 citations · publishing 2023-2025
JAMA Psychiatry February 12, 2025 Brian S. Barnett, Roger D Weiss, Gerard Sanacora 7 citations
This Viewpoint discusses challenges related to ketamine use within psychiatry and offers recommendations for optimizing patient safety.
Frontiers in Psychology 2025 Diane Joss, Joseph Rosansky, Paula Gardiner et al. 1 citation
Adverse childhood experiences (ACE) are transdiagnostic developmental risk factors for various mental and physical health issues, including Opioid Use Disorder (OUD). Existing research demonstrated ACE not only affects the onset, severity, and comorbidity of disorders, but also affects treatment responses. To investigate whether and how ACE modulates treatment effects of Mindfulness Based...
JAMA Psychiatry 2023 Brian D Kiluk, Bethea A Kleykamp, Sandra D Comer et al. 22 citations
Novel treatments for opioid use disorder (OUD) are needed to address both the ongoing opioid epidemic and long-standing barriers to existing OUD treatments that target the endogenous μ-opioid receptor (MOR) system. The goal of this review is to highlight unique clinical trial design considerations for the study of emerging treatments for OUD that address targets beyond the MOR system. In...